Solid Phase Synthesis of Phosphopeptides Incorporating 2,2-Dimethyloxazolidine Pseudoproline Analogs: Evidence for trans Leu-Pro Peptide Bonds in Stat3 Inhibitors
Tóm tắt
To answer the question of whether the conformation of the Leu-Pro bond is cis or trans in Ac-pTyr-Leu-Pro-Gln-Thr-Val-NH2 when complexed with the SH2 domain of Stat3, we substituted 2,2-dimethyloxazolidines derived from serine (Ser(ΨMe,Mepro)) and threonine (Thr(ΨMe,Mepro)) for proline. The 2,2-dimethyloxazolidine and 2,2-dimethylthiazolidine pseudoproline (ΨPro) analogs induce predominantly cis Xxx-ΨPro peptide bonds. As these ΨPro analogs are acid-labile, the phosphopeptides were synthesized using Fmoc-based SPPS using unprotected phosphotyrosine and 4-hydroxybenzoate as the linker that allowed release from the support by alkaline ammonolysis, conditions that kept the oxazolidine rings intact. Incorporation of Ser(ΨMe,Mepro) resulted in 69% cis Leu-ΨPro bond content in aqueous solution whereas that for Thr(ΨMe,Mepro) analog was 63%. Affinities for Stat3 were 3–5 fold lower than the lead compound and were inversely correlated with cis content. Thus we conclude that the Leu-Pro peptide bond is trans when the peptide is bound to Stat3.
Tài liệu tham khảo
Arshady, R., Atherton, E., Clive, D. L. J. and Sheppard, R. C.: 1981, J. Chem. Soc. Perkin Trans. 1, 529–537
Atherton, E., Logan, C. J. and Sheppard, R. C.: 1981, J. Chem. Soc. Perkin Trans. 1, 538–546
Atherton, E., Pinori, M., Sheppard, R. C. (1985) J. Chem. Soc. Perkin Trans. 1 10, 2057–2064
Becker, S., Gromer B., Muller C. W.: 1998, Nature 394, 145–151
Bowman, T., Garcia, R., Turkson, J., Jove, R. 2000, Oncogene 19, 2474–2488
Breeze, A. L., Kara, B. V., Barratt, D. G., Anderson, M., Smith, J. C., Luke, R. W., Best, J. R., Cartlidge, S. A. (1996) EMBO J. 15, 3579–3589
Bromberg, J. (2002) J. Clin. Invest. 109, 1139–1142
Bromberg, J., Darnell, J. E. Jr. (2000) Oncogene 19, 2468–2473
Buettner, R., Mora, L. B., Jove, R. (2002) Clin. Cancer Res. 8, 945–954
Burke, W. M., Jin, X., Lin, H.-J., Huang, M., Liu, R., Reynolds, R. K., Lin, J. (2001) Oncogene 20, 7925–7934
Catlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernandez-Luna, J. L., Nunez, G., Dalton, W. S., Jove, R. (1999) Immunity 10(1), 105–115
Coleman IV D. R., Ren, Z., Mandal, P. K., Cameron, A. G., Dyer, G. A., Muranjan, S., Campbell, M., Chen, X., McMurray, J. S. (2005) J. Med. Chem. 48, 6661–6670
Darnell, J. E. Jr. (2002) Nat. Rev. Cancer, 2, 740–749
Dumy, P., Keller, M., Ryan, D. E., Rohwedder, B., Woehr, T., Mutter, M. (1997) J. Am. Chem. Soc. 119, 918–925
Ettmayer, P., France, D., Gounarides, J., Jarosinski, M., Martin, M. S., Rondeau, J. M., Sabio, M., Topiol, S., Weidmann, B., Zurini, M., Bair, K. W. (1999) J. Med. Chem. 42, 971–980
Gerhartz, C., Heesel, B., Sasse, J., Hemmann, U., Landgraf, C., Schneider-Mergener, J., Horn, F., Heinrich, P. C., Graeve, L. (1996) J. Biol. Chem. 271, 12991–12998
Grandis, J. R., Drenning, S. D., Chakraborty, A., Zhou, M.-Y., Zeng, Q., Pitt, A. S., Tweardy, D. J. (1998) J. Clin. Invest. 102, 1385–1392
Grandis, J. R., Drenning, S. D., Zeng, Q., Watkins, S. C., Melhem, M. F., Endo, S., Johnson, D. E., Huang, L., He, Y. and Kim, J. D.: 2000, Proc. Natl. Acad. Sci. U.S.A. 97, 4227–4232
Gray, M. J., Zhang, J., Ellis, L. M., Semenza, G. L., Evans, D. B., Watowich, S. S., Gallick, G. E. (2005) Oncogene 24, 3110–3120
Keller, M., Sager, C., Dumy, P., Schutkowski, M., Fischer, G. S., Mutter, M. (1998) J. Am. Chem. Soc. 120, 2714–2720
Keller, M., Boissard, C., Patiny, L., Chung, N. N., Lemieux, C., Mutter, M., Schiller, P. W. (2001) J. Med. Chem. 44, 3896–3903
Levy, D. E., Darnell, J. E., Jr. (2002) Nat. Rev. Mol. Cell Biol. 3, 651–662
Motulsky, H. J. and Christopoulos A.: 2003, Fitting models to biological data using linear and nonlinear regression. A practical guide to curve fitting, Graphpad Software Inc., San Diego, CA, http://www.graphpad.com
Niu, G., Heller, R., Catlett-Falcone, R., Coppola, D., Jaroszeski, M., Dalton, W., Jove, R., Yu, H. (1999) Cancer Res. 59, 5059–5063
Ottinger, E. A., Shekels, L. L., Bernlohr, D. A. and Barany, G.: 1993, Biochemistry 32, 4354–4361.
Ren, Z., Cabell, L. A., Schaefer, T. S., McMurray, J. S. (2003) Bioorg. Med. Chem. Lett. 13, 633–636
Ruckle, T., De Lavallaz, P., Keller, M., Dumy, P., Mutter, M. (1999) Tetrahedron 55, 11281–11288
Schust, J. and Berg, T. A.: 2004, Anal. Biochem. 330, 114–118
Stahl, N., Farruggella, T. J., Boulton, T. G., Zhong, Z., Darnell, J. E., Yancopoulos, G. D. (1995) Science 267, 1349–1353
Stark, G. R., Kerr I. M., Williams B. R., Silverman R. H., Schreiber R. D.: 1998, Annu. Rev. Biochem. 67, 227–264
Tuchscherer, G., Grell, D., Tatsu, Y., Durieux, P., Fernandez-Carneado, J., Hengst, B., Kardinal, C. and Feller, S.: 2001, Angew. Chem. Int. Ed. 40, 2844–2848
Wiederkehr-Adam, M., Ernst, P., Muller, K., Bieck, E., Gombert, F. O., Ottl, J., Graff, P., Grossmuller, F., Heim, M. H. (2003) J. Biol. Chem. 278, 16117–16128
Wittelsberger, A., Keller, M., Scarpellino, L., Patiny, L., Acha-Orbea, H., Mutter, M. (2000) Angew. Chem., Int. Ed. 39, 1111–1115
Wittelsberger, A., Patiny, L., Slaninova, J., Barberis, C., Mutter, M. (2005) J. Med. Chem. 48, 6553–6562
Xu R. X., Word J. M., Davis D. G., Rink M. J., Willard D. H. Jr., Gampe R. T. Jr.: 1995, Biochemistry 34, 2107–2121
Xi, S., Gooding, W. E., Grandis, J. R. (2005) Oncogene, 24, 970–979
Yu H., Jove R.: 2004, Nat. Rev. Cancer 4, 97–105